Non-opioid Analgesic Patch Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4131268
- 89 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Non-opioid Analgesic Patch market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Non-opioid Analgesic Patch market segmented into
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
Based on the end-use, the global Non-opioid Analgesic Patch market classified into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Based on geography, the global Non-opioid Analgesic Patch market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
GlaxoSmithKline Plc
Pfizer, Inc.
Teikoku Seiyaku Co., Ltd.
Mylan N.V.
Hisamitsu Pharmaceutical Co.,Inc
Acorda Therapeutics, Inc
Endo International plc
Allergan
Teh Seng Pharmaceutical Mfg
IBSA Institut Biochimque SA
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NON-OPIOID ANALGESIC PATCH INDUSTRY
2.1 Summary about Non-opioid Analgesic Patch Industry
2.2 Non-opioid Analgesic Patch Market Trends
2.2.1 Non-opioid Analgesic Patch Production & Consumption Trends
2.2.2 Non-opioid Analgesic Patch Demand Structure Trends
2.3 Non-opioid Analgesic Patch Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lidocaine Patches
4.2.2 Diclofenac Patches
4.2.3 Methyl Salicylate Patches
4.2.4 Capsaicin Patches
4.2.5 Ketoprofen Patches
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Online Pharmacies
4.3.3 Independent Pharmacies & Drug Stores
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Methyl Salicylate Patches
5.2.4 Capsaicin Patches
5.2.5 Ketoprofen Patches
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Online Pharmacies
5.3.3 Independent Pharmacies & Drug Stores
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lidocaine Patches
6.2.2 Diclofenac Patches
6.2.3 Methyl Salicylate Patches
6.2.4 Capsaicin Patches
6.2.5 Ketoprofen Patches
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Online Pharmacies
6.3.3 Independent Pharmacies & Drug Stores
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lidocaine Patches
7.2.2 Diclofenac Patches
7.2.3 Methyl Salicylate Patches
7.2.4 Capsaicin Patches
7.2.5 Ketoprofen Patches
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Online Pharmacies
7.3.3 Independent Pharmacies & Drug Stores
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lidocaine Patches
8.2.2 Diclofenac Patches
8.2.3 Methyl Salicylate Patches
8.2.4 Capsaicin Patches
8.2.5 Ketoprofen Patches
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Online Pharmacies
8.3.3 Independent Pharmacies & Drug Stores
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lidocaine Patches
9.2.2 Diclofenac Patches
9.2.3 Methyl Salicylate Patches
9.2.4 Capsaicin Patches
9.2.5 Ketoprofen Patches
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Online Pharmacies
9.3.3 Independent Pharmacies & Drug Stores
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GlaxoSmithKline Plc
10.1.2 Pfizer, Inc.
10.1.3 Teikoku Seiyaku Co., Ltd.
10.1.4 Mylan N.V.
10.1.5 Hisamitsu Pharmaceutical Co.,Inc
10.1.6 Acorda Therapeutics, Inc
10.1.7 Endo International plc
10.1.8 Allergan
10.1.9 Teh Seng Pharmaceutical Mfg
10.1.10 IBSA Institut Biochimque SA
10.2 Non-opioid Analgesic Patch Sales Date of Major Players (2017-2020e)
10.2.1 GlaxoSmithKline Plc
10.2.2 Pfizer, Inc.
10.2.3 Teikoku Seiyaku Co., Ltd.
10.2.4 Mylan N.V.
10.2.5 Hisamitsu Pharmaceutical Co.,Inc
10.2.6 Acorda Therapeutics, Inc
10.2.7 Endo International plc
10.2.8 Allergan
10.2.9 Teh Seng Pharmaceutical Mfg
10.2.10 IBSA Institut Biochimque SA
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Non-opioid Analgesic Patch Product Type Overview
Table Non-opioid Analgesic Patch Product Type Market Share List
Table Non-opioid Analgesic Patch Product Type of Major Players
Table Brief Introduction of GlaxoSmithKline Plc
Table Brief Introduction of Pfizer, Inc.
Table Brief Introduction of Teikoku Seiyaku Co., Ltd.
Table Brief Introduction of Mylan N.V.
Table Brief Introduction of Hisamitsu Pharmaceutical Co.,Inc
Table Brief Introduction of Acorda Therapeutics, Inc
Table Brief Introduction of Endo International plc
Table Brief Introduction of Allergan
Table Brief Introduction of Teh Seng Pharmaceutical Mfg
Table Brief Introduction of IBSA Institut Biochimque SA
Table Products & Services of GlaxoSmithKline Plc
Table Products & Services of Pfizer, Inc.
Table Products & Services of Teikoku Seiyaku Co., Ltd.
Table Products & Services of Mylan N.V.
Table Products & Services of Hisamitsu Pharmaceutical Co.,Inc
Table Products & Services of Acorda Therapeutics, Inc
Table Products & Services of Endo International plc
Table Products & Services of Allergan
Table Products & Services of Teh Seng Pharmaceutical Mfg
Table Products & Services of IBSA Institut Biochimque SA
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Non-opioid Analgesic Patch Market Forecast (Million USD) by Region 2021f-2026f
Table Global Non-opioid Analgesic Patch Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Non-opioid Analgesic Patch Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Non-opioid Analgesic Patch Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
